“…Among patients with COVID-19, the incidence of IHCA for non-ICU patients was 2.2% and 15.4% for ICU patients [ 48 ]; cardiac arrest most often occurred on hospital day 4 [ 18 , 26 ]. For IHCA patients with COVID-19 infection, ROSC varied from 13.2–54%, survival to hospital discharge ranges from 0 to 12%, and good neurologic outcomes 0–0.7% [ 14 , 15 , 17 , 44 , [48] , [49] , [50] , [51] ]; when considering inpatient location of cardiac arrest, survival to hospital discharge was worse for non-ICU patients (0.7%) versus ICU patients (9.1%) [ 48 ]. As noted in the OHCA population, co-morbid conditions also occurred with greater frequency among inpatients [ 49 ].…”